消化性潰瘍治療薬市場：消化性潰瘍タイプ別、薬剤タイプ別、流通チャネル別-2023-2030年の世界予測

消化性潰瘍治療薬市場は、予測期間中のCAGRは5.15%で、2022年の43億米ドルから2030年には64億3,000万米ドルに達すると予測されています。

世界の消化性潰瘍治療薬市場

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは消化性潰瘍治療薬市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.消化性潰瘍治療薬市場の市場規模および予測は？

2.消化性潰瘍治療薬市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.消化性潰瘍治療薬市場における競争戦略の窓とは？

4.消化性潰瘍治療薬市場の最新技術動向と規制の枠組みは？

5.消化性潰瘍治療薬市場における主要ベンダーの市場シェアは？

6.消化性潰瘍治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の拡大に伴う消化性潰瘍の有病率の高さ
    • 消化性潰瘍に対する意識の高まりと診断技術の進歩
    • 患者中心のケアと個別化された消化性潰瘍治療の重視の高まり
  • 抑制要因
    • 消化性潰瘍治療薬のコストが高い
  • 機会
    • より新しく効果的な消化性潰瘍治療薬のイントロダクション
    • 遠隔医療とeコマースプラットフォームの導入の拡大
  • 課題
    • 消化性潰瘍治療薬に関連する悪影響
• 市場セグメンテーション分析
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 消化性潰瘍治療薬市場消化性潰瘍の種類別

• 十二指腸潰瘍
• 胃潰瘍

第7章 消化性潰瘍治療薬市場薬剤の種類別

• 細胞保護剤
• H2ブロッカー
• プロトンポンプ阻害剤（PPI）

第8章 消化性潰瘍治療薬市場：流通チャネル別

• オフライン
  • 病院
  • 小売薬局
• オンライン

第9章 南北アメリカの消化性潰瘍治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の消化性潰瘍治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの消化性潰瘍治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Abbott Laboratories
  • AbbVie Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cadila Healthcare Ltd.
  • Century Pharmaceuticals Ltd.
  • Daewoong Pharmaceutical Co. LTD.
  • Dr. Reddy's Laboratories Ltd
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Hikma Pharmaceuticals PLC
  • Medopharm Pvt Ltd
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Pharmanova India Drugs Pvt. Ltd.
  • Redhill Biopharma Ltd
  • Rosemont Pharmaceuticals Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Ulcerex Pharma
  • USAntibiotics
  • Yuhan Corporation
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. PEPTIC ULCER DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. PEPTIC ULCER DRUGS MARKET SIZE, 2022 VS 2030
• FIGURE 3. PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 6. PEPTIC ULCER DRUGS MARKET DYNAMICS
• FIGURE 7. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2022 VS 2030 (%)
• FIGURE 8. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
• FIGURE 10. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 12. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 14. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 16. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 21. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 22. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PEPTIC ULCER DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 6. PEPTIC ULCER DRUGS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PEPTIC ULCER DRUGS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 9. PEPTIC ULCER DRUGS MARKET SIZE, BY CYTOPROTECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PEPTIC ULCER DRUGS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PEPTIC ULCER DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS (PPIS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 13. PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 15. PEPTIC ULCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. PEPTIC ULCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. PEPTIC ULCER DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 57. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 69. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 73. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 77. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 81. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 85. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 89. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 93. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 102. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 106. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 110. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 114. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 118. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 122. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 126. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 130. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 134. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 138. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 142. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 143. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 144. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 146. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 147. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 148. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 150. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 154. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 158. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 162. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 166. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 170. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 174. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 178. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
• TABLE 186. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 187. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 188. PEPTIC ULCER DRUGS MARKET LICENSE & PRICING

The Peptic Ulcer Drugs Market is projected to reach USD 6.43 billion by 2030 from USD 4.30 billion in 2022, at a CAGR of 5.15% during the forecast period.

Global Peptic Ulcer Drugs Market

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Peptic Ulcer Drugs Market.

Based on Peptic Ulcer Type, market is studied across Duodenal Ulcer and Gastric Ulcer. The Gastric Ulcer is projected to witness significant market share during forecast period.

Based on Drug Type, market is studied across Cytoprotective Agents, H2 Blockers, and Proton Pump Inhibitors (PPIs). The Proton Pump Inhibitors (PPIs) is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals and Retail Pharmacies. The Online is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Peptic Ulcer Drugs Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Peptic Ulcer Drugs Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Peptic Ulcer Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Century Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. LTD., Dr. Reddy's Laboratories Ltd, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Medopharm Pvt Ltd, Merck KGaA, Mylan N.V., Novartis AG, Pfizer Inc., Pharmanova India Drugs Pvt. Ltd., Redhill Biopharma Ltd, Rosemont Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ulcerex Pharma, USAntibiotics, and Yuhan Corporation.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Peptic Ulcer Drugs Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Peptic Ulcer Drugs Market?

3. What is the competitive strategic window for identifying opportunities in the Peptic Ulcer Drugs Market?

4. What are the latest technology trends and regulatory frameworks in the Peptic Ulcer Drugs Market?

5. What is the market share of the leading vendors in the Peptic Ulcer Drugs Market?

6. Which modes and strategic moves are suitable for entering the Peptic Ulcer Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Peptic Ulcer Drugs Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High prevalence of peptic ulcers with expanding geriatric population
    • 5.1.1.2. Growing awareness about peptic ulcers and advancements in diagnostic techniques
    • 5.1.1.3. Increasing emphasis on patient-centric care and personalized peptic ulcer treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of peptic ulcer drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of newer and effective peptic ulcer drugs
    • 5.1.3.2. Growing adoption of telemedicine and e-commerce platforms
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects associated with peptic ulcer drugs
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Peptic Ulcer Drugs Market, by Peptic Ulcer Type

• 6.1. Introduction
• 6.2. Duodenal Ulcer
• 6.3. Gastric Ulcer

7. Peptic Ulcer Drugs Market, by Drug Type

• 7.1. Introduction
• 7.2. Cytoprotective Agents
• 7.3. H2 Blockers
• 7.4. Proton Pump Inhibitors (PPIs)

8. Peptic Ulcer Drugs Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
  • 8.3.1. Hospitals
  • 8.3.2. Retail Pharmacies
• 8.3. Online

9. Americas Peptic Ulcer Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Peptic Ulcer Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Peptic Ulcer Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Abbott Laboratories
  • 13.1.2. AbbVie Inc.
  • 13.1.3. AstraZeneca PLC
  • 13.1.4. Boehringer Ingelheim International GmbH
  • 13.1.5. Cadila Healthcare Ltd.
  • 13.1.6. Century Pharmaceuticals Ltd.
  • 13.1.7. Daewoong Pharmaceutical Co. LTD.
  • 13.1.8. Dr. Reddy's Laboratories Ltd
  • 13.1.9. Eisai Co. Ltd.
  • 13.1.10. F. Hoffmann-La Roche Ltd.
  • 13.1.11. GlaxoSmithKline PLC
  • 13.1.12. Hikma Pharmaceuticals PLC
  • 13.1.13. Medopharm Pvt Ltd
  • 13.1.14. Merck KGaA
  • 13.1.15. Mylan N.V.
  • 13.1.16. Novartis AG
  • 13.1.17. Pfizer Inc.
  • 13.1.18. Pharmanova India Drugs Pvt. Ltd.
  • 13.1.19. Redhill Biopharma Ltd
  • 13.1.20. Rosemont Pharmaceuticals Limited
  • 13.1.21. Takeda Pharmaceutical Company Limited
  • 13.1.22. Teva Pharmaceutical Industries Ltd.
  • 13.1.23. Ulcerex Pharma
  • 13.1.24. USAntibiotics
  • 13.1.25. Yuhan Corporation
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing